Antidepressants Flashcards
Depression
- > 5 sx present during same 2 week period
- Represent a change from previous functioning
- At least one of the sx has to be depressed mood or loss interest/pleasure (Anhedonia)
*Do not include sx that are due to a general medical condition, or mood incongruent delusions or hallucinations
Depression Sx
- Need to cause clinically significant distress or impairment in social, occupational or other important areas of functioning
SIGECAPS S= sleep I= intrest G= guilt E= energy C= concentration A= appetite P= psychomotor S= suicidal
Antidepressant Classes
- SSRIs
- SNRIs
- Serotonin Modulators
- Tricyclics
- MAOIs
- Atypicals
All Antidepressants
- Blackbox warning for suicidality in pts
Serotonin Syndrome
- Too much serotonin (usually too many serotonin drugs, can happen with monotherapy)
- RARE
- Sx: mental status changes (agitation, hallucinations, coma); autonomic instability (tachycardia, HTN, hyperthermia); neuromuscular aberrations (hyperreflexia, incoordination, tremor); GI sx (N/V/D); Ocular clonus, mydriasis
Bleed risk
- Increased bleed associated with SSRIs
- Blocks 5-HT transport into platelet, interfering with platelet activation, aggregation
- Intracranial hemorrhage, GI bleed
SSRIs
Fluvoxamine (Luvox) Fluoxetine (Prozac) Paroxetine (Paxil) Citalopram (Celexa) Escitalopram (Lexapro) Sertraline (Zoloft) Vortioxetine (Brintellix)
- Selective serotonin reuptake inhibitors
- MOA: Block presynaptic serotonin transporter (Leaves more serotonin available for us)
- ADR: NAUSEA/VOMITING, INSOMNIA, wt gain, HA, bruxism (teeth grinding), erectile dysfunction/decreased libido, diaphoresis, orthostasis, akathisia, osteopenia, GI bleed, some anticholinergic effects
- DRUG INTERACTIONS: other serotonin drugs, 2D6 inhibitors
- PREGNANCY: 1st trimester (associated w/ cardiac defects); 3rd trimester (low birth wt, prematurity, neonatal withdrawal, persistent pulmonary HTN of newborn)
Fluoxetine (Prozac)
- For Major Depressive Disorder, OCD, Panic Disorder, bulimia
- Lease wt gain
- Long t1/2
- Can be activating– take in the morning
- Potential for drug interactions (2D6 inhibitor)
Paroxetine (Paxil, Pexeva)
- For MDD, OCD, Social Anxiety Disorder, General Anxiety Disorder
- Most sedating, wt gain, sexual dysfunction, anticholindergic AEs
- Shortest t1/2
- High risk of drug interaction (2D6 inhibition)
Sertraline (Zoloft)
- For MDD, OCD, Panic Disorder, PTSD, PreMenstrual Dysphoric Disorder, SAD
- Few drug interactions (2D6 inhibition at higher doses)
- Benefit in pts with depression and CVD
- ADR: dry mouth, sedation, insomnia, tremor, dizziness, sexual dysfunction
Escitalopram (Lexapro)
- For MDD, GAD
- Few drug interactions
- ADR: N, sedation, insomnia, sexual side effects
Citalopram (Celexa)
- For depression
- Lowest risk of sexual side effects
- Few drug interactions
- Risk of QTC prolongation
SNRIs
Venlafaxine (Effexor) Desvenlafaxine (Pristiq) Trintellix (Vortioxetine) Duloxetine (Cymbalta) Milnacipran (Savella) Levomilnacipran (Fetzima)
- Serotonin-norepinephrine reuptake inhibitors
- MOA: binds 5HT and NE receptor transporters
- INDICATIONS: Depression, Anxiety disorder (GAD, PTSD, SAD, PD)
- Neuropathic pain/chronic pain: Duloxetine, Venlafaxine
- Fibromyalgia: Milnacipran
- ADR: HTN, hyperlipidemia, dry mouth, HA, sexual dysfunction, insomnia, N/V, akathisia, diaphoresis, wt changes
- DRUG INTERACTIONS: other serotonergic drugs, MAOIs, platelet inhibitors, strong 3A4 inhibitors (levomilnacipran), strong 2D6 inhibitors (vortioxetine, duloxetine)
Aytpical antidepressants
Mirtazapine (Remeron)
Bupropion (Wellbutrin)
Mirtazapine (Remeron)
- Major depressive disorder
- MOA: increases central NE and 5HT activity; 5HT receptor antagonist/ H1 receptor antagonist/ peripheral alpha 1 antagonist
- ADR: SEDATION/SOMNOLENCE (caution abt driving, avoid EtOH and other CNS depressants), dizziness, orthostasis, WT GAIN, elevated cholesterol/elevated LFTs, agranulocytosis
Bupropion (Wellbutrin)
- For MDD, smoking cessation
- Can make anxiety worse for anxiety disorders
- MOA: weak NE/DA reuptake inhibitor (does not inhibit 5HT reuptake or MAO)
- ADR: agitation/anxiety/insomnia, wt loss, psychosis/delusions/hallucinations/confusion, HTN, N/V, HA, dry mouth
- CONTRAINDICATION: seizure disorder (eating disorder, withdrawal of EtOH or sedatives)
TCAs
- More likely to cause suicide effects compared with SSRI/SNRI
Amitriptyline (Elavil) Doxepin (Sinequan) Clomipramine Imipramine (Tofranil) Desipramine (Norpramin)
- MOA: SNRI/anticholinergic action/ direct alpha-adrenergic blockade/ membrane stabilizing effect on the myocardium (block the cardiac myocyte fast Na channels)
- INDICATIONS: depression, anxiety, bipolar disorder, OCD, neuropathic pain, migraine prophylaxis
- ADR: anticholinergic effects (dry mouth, urinary retention, sedation), arrhythmia, sexual dysfunction, fall risk, diaphoresis
- CYP 2D6 substrate: potential for toxicity– 2D6 inhibitors (SSRIs); MAOI; anticholinergics; Sympathomimetics; Cimetidine
TCA overdose
- 10 day supply taken all at once can be fatal
- Seizures
- Decreased contractility, alpha adrenergic effects (Hypotension)
- CV sx: palpitation, chest pain, hypotension
- CNS sx: convulsion, decreased mental status, respiratory depression, drowsiness, coma
- Peripheral sx: dry mouth, dry skin, urinary retention, blurred vision
5HT modulators
Trazodone (Desyrel, Olepto)
Trazodone (Desyrel, Olepto)
- Indicated for depression
- OFF LABEL: FOR SLEEP
- MOA: 5HT receptor antagonist and reuptake inhibitor
- ADR: sedation/somnolence, HA/dizziness/dry mouth, Orthostasis/long QT/arrhythmia, priapsism
Vilazodone (Viibryd)
- For depression
- MOA: 5HT receptor partial agonist and reuptake
- ADR: sedation/somnolence, HA/dizziness/dry mouth, Orthostasis/long QT/arrhythmia, priapsism
- P450 3A4 substrate
MAOIs
- Last line for depression (for those who failed or not responded to other antidepressants)
- MOA: nonselective monoamine oxidase inhibitors (increases level of 5HT, NE, DA)
- ADR: serotonin syndrome, sexual dysfunction, myoclonus, orthostasis, HTN crisis, dizziness/drowsiness, C/dry mouth, wt gain
- CONTRAINDICATION: HTN, CVD, other MAOIs/sympathomimetics/CNS depressants; antihypertensive, diuretics, antihistamine, sedative or anesthetic drugs; bupropion????
Supplements
St John’s Wort
St John’s Wort
- Likely effective for depression
- Contain hyperforin, hypericin (melatonin, adhyperforin)
- Modulates 5HT, NE, DA (may inhibit reuptake)
- ADR: INSOMNIA (Take in morning); vivid dreams; restlessness, anxiety, agitation; D, dry mouth; dizziness; HA; rash; hypoglycemia; paresthesias
- Potent P450 inducer (3A4, 2C19, 1A2): increases OCP estrogen metabolism; reduces digoxin, imatinib, irinotecan levels
- Potential for serotonin syndrome
Guidelines depression treatment
- First line: SSRI, SNRI, bupropion, mirtazapine
- Choose based on: pt preference; nature of prior response to medication; safety, tolerability, and anticipate SE; co-occuring psychiatric or general medical conditions; pharmacological properties of the medication; cost
- At lease 4 weeks for full effects of medication
- Treatment for adults with major depressive disorder (either Cognitive Behavior Therapy or Second Generation Antidepressants– SSRI/SNRI)